Resmed (RMD) Current Assets (2010 - 2026)

Resmed has reported Current Assets for 17 years, with the latest figure at $4.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 26.67% year-over-year to $4.1 billion; the trailing twelve-month figure through Mar 2026 stood at $4.1 billion (up 26.67% YoY), and the FY2025 full-year result was $3.5 billion, up 48.69% from the prior year.
• Current Assets for Q1 2026 stood at $4.1 billion, up from $3.8 billion in the prior quarter.
• The five-year high for Current Assets was $4.1 billion in Q1 2026, with the low at $1.7 billion in Q1 2022.
• Historically, Current Assets has averaged $2.7 billion across 5 years, with a median of $2.4 billion in 2023.
• Annual changes were most pronounced in 2022 — Current Assets surged 50.28% — and 2024, when it retreated 0.43%.
• Resmed's Current Assets stood at $2.3 billion in 2022, then gained by 2.28% to $2.4 billion in 2023, then climbed by 19.26% to $2.8 billion in 2024, then surged by 34.65% to $3.8 billion in 2025, then advanced by 6.42% to $4.1 billion in 2026.
• The last three Current Assets figures came in at $4.1 billion (Q1 2026), $3.8 billion (Q4 2025), and $3.6 billion (Q3 2025), per Business Quant data.